S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

BioPharma Credit Share Forecast, Price & News

GBX 77.50
0.00 (0.00%)
(As of 07/1/2022 09:00 PM ET)
Today's Range
50-Day Range
52-Week Range
14,458 shs
Average Volume
Market Capitalization
£1.06 billion
P/E Ratio
Dividend Yield
Price Target

BioPharma Credit MarketRank™ Forecast

Analyst Rating
Short Interest
Dividend Strength
Based on Four Factors
News Sentiment
Insider Trading
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.53 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive BPCP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter.

BioPharma Credit logo

About BioPharma Credit (LON:BPCP) Stock

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.

BPCP Stock News Headlines

BioPharma Credit (LON:BPCP) Reaches New 1-Year Low at $79.00
See More Headlines

Industry, Sector and Symbol

Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
£103.88 million
Cash Flow
GBX 7.04 per share
Book Value
GBX 99.30 per share


Outstanding Shares
Free Float
Market Cap
£1.06 billion
Not Optionable

BioPharma Credit Frequently Asked Questions

How has BioPharma Credit's stock performed in 2022?

BioPharma Credit's stock was trading at GBX 80 on January 1st, 2022. Since then, BPCP stock has decreased by 3.1% and is now trading at GBX 77.50.
View the best growth stocks for 2022 here

Is BioPharma Credit a good dividend stock?

BioPharma Credit(LON:BPCP) pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 7.34%. BPCP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of BioPharma Credit is 112.90%. Payout ratios above 75% are not desirable because they may not be sustainable.

Who are BioPharma Credit's key executives?

BioPharma Credit's management team includes the following people:
  • Mr. Pedro Gonzalez de Cosio, Investment Mang.
  • Mr. Pablo Gerardo Legorreta, Investment Mang. (Age 58)
  • Mr. Martin G. Friedman, Investment Mang. (Age 57)

What is BioPharma Credit's stock symbol?

BioPharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCP."

How do I buy shares of BioPharma Credit?

Shares of BPCP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is BioPharma Credit's stock price today?

One share of BPCP stock can currently be purchased for approximately GBX 77.50.

How much money does BioPharma Credit make?

BioPharma Credit (LON:BPCP) has a market capitalization of £1.06 billion and generates £103.88 million in revenue each year.

How can I contact BioPharma Credit?

The official website for BioPharma Credit is www.bpcruk.com. The company can be reached via phone at 44 13 9247 7500.

This page (LON:BPCP) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.